Prostate
Cancer
Drug dramatically shrinks Prostate Tumors, study finds - July 23, 2008
There is a general sense in the prostate cancer community that this agent is
extremely promising and is very likely to have an important role in the
management of prostate cancer patients,' said Dr. Howard M. Sandler, a
radiation oncologist at the University of Michigan who is a spokesman for the
American Society of Clinical Oncology.'It's pretty safe to say that we are
going to have a lot more to offer patients when this drug gets approved,' added
Dr. Robert Reiter, a urologist at UCLA's Jonsson Comprehensive Cancer Center
who was not involved in the research.
Radiation
helps even when Prostate Cancer returns – June 17, 2008
Radiation therapy can help prolong the lives of men
with aggressive prostate cancer whose tumors return after surgery, U.S.
researchers said on Tuesday.
Radiation therapy given within two years of recurrence
cut the risk of dying from prostate cancer by two-thirds, compared with those
who got no additional treatment, they said.
A new prostate cancer vaccine may give hope to men
with metastatic prostate cancer by enabling their immune systems to fight the
disease. Researchers from the
University
of
Iowa
presented data on the adenovirus/PSA (Ad/PSA) vaccine during the Annual
Scientific Meeting of the American Urological Association in
Orlando
.
In recent years, the concept of vaccine immunotherapy for advanced prostate
cancer has become increasingly high profile as research has expanded. Major
advances in the field have contributed significantly to the discussion of this
important cancer therapy as researchers explore new ways to prolong survival
and improve the quality of life in patients with metastatic disease.
Prostate-screening exams may miss cancer in obese patients, study shows
– November 27, 2007
Higher blood volumes probably cause lower
concentrations of prostate-specific antigen, or PSA, in obese prostate cancer
patients, reports a study, leading the authors to speculate screening with PSA
tests might miss some cancers in obese men.
Study Supports Change to Prostate Cancer Biopsy -
October 2, 2007
Adding an extra step to the standard test for prostate
cancer might improve treatment for some men, a new study finds.
Glaxo's Avodart and Flomax Help Prostate, Study Says (Update1) -
September 4, 2007
GlaxoSmithKline Plc's Avodart combined with Boehringer
Ingelheim GmbH's Flomax improved symptoms of enlarged prostate gland better
than either drug alone, a study found.
HIS
HEALTH - Diet and prostate cancer - August 15, 2007
One's diet is believed to play an important role in
the causation of prostate cancer. Epidemiological studies, looking at different
populations where the incidence of prostate cancer varies widely, suggest that
differences in diet may partly account for these variations.
|